BioLife Solutions
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $30,571 | $28,328 | $31,727 | $32,732 |
Gross Profit | 21,806 | 14,893 | 11,647 | 8,336 |
EBITDA | 853 | -4,375 | -7,605 | -10,536 |
EBIT | -1,464 | -6,737 | -9,883 | -12,919 |
Net Income | -1,703 | -20,719 | -10,221 | -13,383 |
Net Change In Cash | 30,571 | 28,328 | 31,727 | 32,732 |
Free Cash Flow | 3,688 | 5,464 | -4,831 | 1,330 |
Cash | 23,977 | 22,014 | 29,725 | 35,438 |
Basic Shares | 46,175 | 46,004 | 45,432 | 44,822 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $143,271 | $161,759 | $119,156 | $48,087 |
Gross Profit | 46,752 | 53,822 | 37,748 | 27,441 |
EBITDA | -45,238 | -23,190 | -17,784 | 1,070 |
EBIT | -57,533 | -43,148 | -32,702 | -4,735 |
Net Income | -66,427 | -139,805 | -8,383 | 2,667 |
Net Change In Cash | 143,271 | 161,759 | 119,156 | 48,087 |
Cost of Revenue | 84,008 | |||
Free Cash Flow | -18,879 | -18,874 | -13,221 | 1,882 |
Cash | 35,407 | 19,442 | 69,870 | 90,456 |
Basic Shares | 43,719 | 42,481 | 38,503 | 27,306 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.01 |
2024-06-30 | -$0.50 |
2024-03-31 | -$0.23 |
2023-12-31 | -$0.30 |
